Published

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Date: 2023-12-31
Source: PubMed
DOI: 10.1016/j.biopha.2023.115775
PubMed: 37944438

Authors

Madrid-Gambin F Fabregat-Safont D Gomez-Gomez A Olesti E Mason NL Ramaekers JG Pozo OJ

Watch author

Derived topics and classifications

psilocybin Pharmacology Mechanism of Action Consciousness Review Article Drug Interactions Metabolomics Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine2026-05-01 Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.2023-12-31

Related papers

Psychedelics as potent anti-inflammatory therapeuticsNeuropharmacology · 2022-08-22 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01